28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006–2017

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite ongoing food safety measures in the United States, foodborne illness continues to be a substantial health burden. The 10 U.S. sites of the Foodborne Diseases Active Surveillance Network (FoodNet)* monitor cases of laboratory-diagnosed infections caused by nine pathogens transmitted commonly through food. This report summarizes preliminary 2017 data and describes changes in incidence since 2006. In 2017, FoodNet reported 24,484 infections, 5,677 hospitalizations, and 122 deaths. Compared with 2014–2016, the 2017 incidence of infections with Campylobacter, Listeria, non-O157 Shiga toxin–producing Escherichia coli (STEC), Yersinia, Vibrio, and Cyclospora increased. The increased incidences of pathogens for which testing was previously limited might have resulted from the increased use and sensitivity of culture-independent diagnostic tests (CIDTs), which can improve incidence estimates ( 1 ). Compared with 2006–2008, the 2017 incidence of infections with Salmonella serotypes Typhimurium and Heidelberg decreased, and the incidence of serotypes Javiana, Infantis, and Thompson increased. New regulatory requirements that include enhanced testing of poultry products for Salmonella † might have contributed to the decreases. The incidence of STEC O157 infections during 2017 also decreased compared with 2006–2008, which parallels reductions in isolations from ground beef. § The declines in two Salmonella serotypes and STEC O157 infections provide supportive evidence that targeted control measures are effective. The marked increases in infections caused by some Salmonella serotypes provide an opportunity to investigate food and nonfood sources of infection and to design specific interventions. FoodNet conducts active, population-based surveillance for laboratory-diagnosed infections caused by Campylobacter, Cryptosporidium, Cyclospora, Listeria, Salmonella, STEC, Shigella, Vibrio, and Yersinia in 10 sites that account for approximately 15% of the U.S. population (an estimated 49 million persons in 2016). FoodNet is a collaboration among CDC, 10 state health departments, the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA-FSIS), and the Food and Drug Administration (FDA). Laboratory-diagnosed bacterial infections are defined as isolation of bacteria from a clinical specimen by culture or detection by a CIDT. CIDTs detect bacterial antigens, nucleic acid sequences, or, for STEC, Shiga toxin or Shiga toxin genes. ¶ A CIDT-positive–only bacterial infection is a positive CIDT result without culture confirmation. Listeria cases are defined as isolation of L. monocytogenes or detection by a CIDT from a normally sterile site or from placental or fetal tissue in the instance of miscarriage or stillbirth. Laboratory-diagnosed parasitic infections are defined as detection of the parasite from a clinical specimen. Hospitalizations and deaths within 7 days of specimen collection are attributed to the infection. Surveillance for physician-diagnosed postdiarrheal hemolytic uremic syndrome (HUS) is conducted through a network of nephrologists and infection preventionists and hospital discharge data review. This report includes pediatric HUS cases identified during 2016, the most recent year for which data are available. Incidence per 100,000 population was calculated by dividing the number of infections in 2017 by the U.S. Census estimates of the surveillance area population for 2016. Incidence measures include all laboratory-diagnosed infections reported. A negative binomial model with 95% confidence intervals (CIs) was used to estimate change in incidence during 2017 compared with that during 2014–2016 and 2006–2008. Because of large changes in testing practices since 2006, incidence comparisons with 2006–2008 used only culture-confirmed bacterial infections, and comparisons with 2014–2016 used culture-confirmed and CIDT-positive–only cases combined. For HUS, 2016 incidence was compared with that during 2013–2015. Cases of Infection, Incidence, and Trends During 2017, FoodNet identified 24,484 cases of infection, 5,677 hospitalizations, and 122 deaths. The incidence of infection per 100,000 population was highest for Campylobacter (19.2) and Salmonella (16.0), followed by Shigella (4.3), STEC (4.2),** Cryptosporidium (3.7), Yersinia (1.0), Vibrio (0.7), Listeria (0.3), and Cyclospora (0.3) (Table 1). The percentage of CIDT-positive–only infections, including those that were culture-negative and those not tested by culture, were Yersinia (51%), Campylobacter (36%), Shigella (31%), Vibrio (29%), STEC (27%), Salmonella (9%), and Listeria (1%) (Figure). Compared with incidence during 2014–2016, the 2017 incidence was significantly higher for Cyclospora (489% increase), Yersinia (166% increase), Vibrio (54% increase), STEC (28% increase), Listeria (26% increase), and Campylobacter (10% increase) (Table 1). Bacterial infections diagnosed by CIDT increased 96% overall (range = 34%–700% per pathogen) in 2017 compared with those diagnosed during 2014–2016. Reflex culture †† was attempted on 71% of CIDT-positive specimens, ranging from 63% for Campylobacter to 100% for Listeria (Figure). Among specimens on which a reflex culture was performed, the percentage of positive cultures ranged from 38% for Vibrio to 90% for Salmonella. TABLE 1 Incidence of bacterial and parasitic infections in 2017 and percentage change compared with 2014–2016 average annual incidence, by pathogen — FoodNet sites,* 2014–2017 † Pathogen 2017 2017 versus 2014–2016 No. of cases Incidence rate§ % Change¶ (95% CI) Bacteria Campylobacter 9,421 19.1 10 (2 to 18) Salmonella 7,895 16.0 -5 (-11 to 1) Shigella 2,132 4.3 -3 (-25 to 25) Shiga toxin–producing E. coli** 2,050 4.2 28 (9 to 50) Yersinia 489 1.0 166 (113 to 234) Vibrio 340 0.7 54 (26 to 87) Listeria 158 0.3 26 (2 to 55) Parasites Cryptosporidium 1,836 3.7 10 (-16 to 42) Cyclospora 163 0.3 489 (253 to 883) Abbreviations: CI = confidence interval; FoodNet = CDC’s Foodborne Diseases Active Surveillance Network. * Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York. † Data for 2017 are preliminary. § Per 100,000 population. ¶ Percentage change reported as increase or decrease. ** For Shiga toxin–producing E. coli, all serogroups were combined because it is not possible to distinguish between serogroups using culture-independent diagnostic tests. Reports that were only Shiga toxin–positive from clinical laboratories and were Shiga toxin–negative at a public health laboratory were excluded (n=518). When these were included, the incidence rate was 5.2, which was a 57% increase (CI = 33% to 85%). FIGURE Number of infections diagnosed by culture or culture-independent diagnostic tests, by pathogen, year, and culture status — FoodNet sites,* 2014–2017†,§ Abbreviations: CIDT = culture-independent diagnostic test; FoodNet = CDC’s Foodborne Diseases Active Surveillance Network; STEC = Shiga toxin–producing Escherichia coli. * Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York. † Data for 2017 are preliminary. § For STEC, all serogroups were combined because it is impossible to distinguish between serogroups using CIDTs. Reports that were only Shiga toxin–positive from clinical laboratories and were Shiga toxin–negative at a public health laboratory were excluded (n=518). The figure above consists of seven bar charts indicating the number of infections diagnosed by culture or culture-independent diagnostic tests by pathogen, year, and culture status from CDC’s Foodborne Diseases Active Surveillance Network (FoodNet) during 2014—2017. Among 6,373 (89%) fully serotyped Salmonella isolates, the five most common were Enteritidis (incidence = 2.6 per 100,000), Typhimurium (1.4), Newport (1.3), Javiana (1.1), and the monophasic variant of Typhimurium, I 4,[5],12:i:- (0.9) (Table 2). Among the 13 most common serotypes, the incidence for Heidelberg in 2017 was 65% lower than during 2006–2008 and 38% lower than during 2014–2016 (Table 2). It was also significantly lower for Typhimurium for both periods (42% and 14%, respectively). TABLE 2 Incidence of infection of the top 13 Salmonella serotypes in 2017 compared with 2006–2008 and 2014–2016 average annual incidence, by pathogen — FoodNet sites,* 2006–2017 † Serotype 2017 2017 versus 2006–2008 2017 versus 2014–2016 Incidence rate§ % Change¶ (95% CI) % Change¶ (95% CI) Enteritidis 2.6 3 (-11 to 20) -8 (-21 to 7) Typhimurium** 1.4 -42 (-48 to -34) -14 (-24 to -2) Newport 1.3 -5 (-22 to 16) -19 (-34 to -2) Javiana 1.1 99 (57 to 153) -7 (-26 to 17) I 4,[5],12:i:-** 0.9 35 (-5 to 74) 1 (-22 to 29) Muenchen 0.4 -13 (-35 to 14) -4 (-28 to 27) Infantis 0.3 60 (19 to 113) -20 (-39 to 6) Montevideo 0.3 -30 (-47 to -8) 24 (-7 to 66) Braenderup 0.3 29 (-5 to 76) 25 (-8 to 70) Saintpaul 0.3 -36 (-53 to -14) -20 (-40 to 9) Thompson 0.3 70 (22 to 138) 32 (-5 to 84) I 13,23:b:- †† 0.3 N/A N/A N/A N/A Heidelberg 0.2 -65 (-75 to -52) -38 (-55 to -15) Abbreviations: CI = confidence interval; FoodNet = CDC’s Foodborne Diseases Active Surveillance Network; N/A = not applicable. * Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York. † Data for 2017 are preliminary. § Per 100,000 population. ¶ Percentage change reported as increase or decrease. ** Percentage change (95% CI) for Typhimurium including monophasic variant (I, 4[5],12:i:-) compared with 2006–2008 and 2014–2016 was -26% (-34% to -17%) and -11% (-20% to 0%), respectively. †† Comparisons could not be calculated for serotype I 13,23,b:I because of sparse data across the entire period. Among 1,473 STEC isolates tested for the O157 antigen, 413 (28%) were determined to be O157. Among the 766 non-O157 STEC isolates with serogroup determined, the most common were O26 (29%), O103 (26%), and O111 (18%). During 2017, the incidence of non-O157 STEC significantly increased 25% (95% CI = 9–44) compared with that during 2014–2016; incidence of STEC O157 was unchanged. However, compared with 2006–2008, the incidence of STEC O157 was significantly lower (35% decrease; 95% CI = 21–46). FoodNet identified 57 cases of HUS in children (incidence = 0.51 per 100,000) during 2016; 35 (61%) occurred among children aged <5 years (incidence = 1.18 per 100,000). The incidence during 2016 compared with that during 2013–2015 was not significantly different among all children or those aged <5 years. The incidence among children aged <5 years significantly decreased 36% (95% CI = 8–55) in 2016 compared with 2006–2008. Discussion Clinical laboratories are steadily increasing the use of CIDTs, particularly DNA-based syndrome panels, to diagnose enteric pathogens ( 2 ). Previously, routine stool tests typically only included methods for identifying Salmonella, Campylobacter, Shigella, and STEC O157 ( 3 ). CIDTs benefit public health by identifying illnesses caused by pathogens not captured routinely by older methods, revealing more accurate incidence estimates for some pathogens. For example, most laboratories required a specific request to test for Cyclospora. Because use of panel tests has risen, routine tests more often include Cyclospora as well as Yersinia, Vibrio, and non-O157 STEC. The increased incidence of these infections in 2017 was most likely driven by the increased use of CIDTs. Although the number of Salmonella infections with CIDT-positive results increased 176% during 2017 compared with 2014–2016, the overall percentage without culture confirmation remained relatively low (9%) because of the high frequency and success of reflex culture, which is necessary for subtyping. Infections caused by serotypes Typhimurium (including I 4,[5],12:i:-) and Heidelberg have decreased considerably over the past 10 years. These declines mirror decreases in broiler chicken samples that yielded Salmonella and, specifically, serotype Heidelberg (USDA-FSIS, unpublished data). These declines might be partly because of industry measures to vaccinate poultry flocks against these serotypes ( 4 ) as well as implementation of measures by USDA-FSIS to decrease Salmonella in poultry and beef products. Despite these decreases, the overall incidence of Salmonella has not substantially declined since 2014–2016, partly because infections with some serotypes have increased. In particular, infections caused by serotypes Javiana, Thompson, and Infantis each increased approximately 50% compared with 2006–2008. Like most serotypes, these have been linked to both food and other exposures, including animal contact ( 5 ). Thus, some of these infections are likely attributable to nonfood exposures. USDA-FSIS also noted an increase of >50% in the percentage of broiler chicken samples that yielded Infantis from 2006 to 2017 (USDA-FSIS, unpublished data). The decreasing availability of STEC serogroup information, attributable to CIDTs, makes interpretation of trends difficult. However, the decreased incidence of HUS among young children during 2016 compared with that during 2006–2008 provides evidence that supports the finding of a decline in STEC O157 infections because most HUS cases are caused by STEC O157 ( 6 ). This decline also mirrors declines in STEC O157 in ground beef during the same period. CIDTs pose challenges to public health when reflex culture is not performed. Without isolates, public health laboratories are unable to subtype pathogens, determine antimicrobial susceptibility, and detect outbreaks. Reflex culture recovery rates vary, which could be attributed to false positives, low numbers of bacteria, storage or transport problems, or insensitive culture techniques ( 7 , 8 ). Furthermore, CIDTs vary in sensitivity and specificity. Evaluations of panel tests have indicated high sensitivity and specificity, differing by test type and manufacturer. The Association of Public Health Laboratories recommends that clinical laboratories culture CIDT-positive specimens ( 9 ). The lack of isolates for 25% of bacterial infections in 2017 is cause for concern. The findings in this report are subject to at least two limitations. First, the changing diagnostic landscape makes interpretation of incidence and trends difficult. In addition to actual increases in infection, increases in reported incidence might be due to some health care providers being more likely to order a CIDT because results are more quickly obtained than with traditional culture methods ( 1 ). Increases in incidence could also be due to increased use of DNA-based syndrome panel tests that diagnose pathogens not captured routinely by older methods. With improved sensitivity and specificity of DNA-based CIDTs, infections that previously would have remained undetected by culture methods might now be detected. Second, changes in incidence can reflect year-to-year variation rather than sustained trends. Most foodborne illnesses can be prevented. New regulatory requirements aimed at reducing contamination of poultry meat might have contributed to decreases in incidence of infections caused by Salmonella serotypes Typhimurium and Heidelberg. Vaccination might also have contributed, but the extent of vaccination in poultry broiler flocks has not been reported. The declines in these and in STEC O157 infections provide supportive evidence that targeted control measures are effective. More control measures are needed and might be achieved with continued implementation of the FDA Food Safety Modernization Act, §§ new or revised meat and poultry performance standards, and enhanced training and guidance for industry and inspection personnel. In particular, measures targeting specific Salmonella serotypes, including vaccination of broiler poultry flocks, might result in a marked decrease in human illness, as has been seen in the United Kingdom ( 10 ). Summary What is already known about this topic? The incidence of infections transmitted commonly through food has remained largely unchanged for many years. Culture-independent diagnostic tests (CIDTs) are increasingly used by clinical laboratories to detect enteric infections. CIDTs benefit public health surveillance by identifying illnesses caused by pathogens not captured routinely by previous laboratory methods. What is added by this report? Decreases in incidence of infection of Shiga toxin–producing Escherichia coli (STEC) O157 and Salmonella serotypes Typhimurium and Heidelberg have been observed over the past 10 years. These declines parallel findings of decreased Salmonella contamination of poultry meat and decreased STEC O157 contamination of ground beef. What are the implications for public health practice? As use of CIDTs continues to increase, higher, more accurate incidence rates might be observed. However, without isolates, public health laboratories are unable to subtype pathogens, determine antimicrobial susceptibility, and detect outbreaks. Further prevention measures are needed to decrease the incidence of infection by pathogens transmitted commonly through food.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The “Decline and Fall” of Nontyphoidal Salmonella in the United Kingdom

          Nontyphoidal Salmonella species are important foodborne pathogens worldwide [1], causing diarrhea, vomiting, nausea, fever, and abdominal pain. Illness has been linked to a wide range of food items including eggs, chicken, beef, pork, salad vegetables, and dairy products, and other risk factors including overseas travel [2–7]. Outbreaks are fairly common [5]. The burden of illness, defined as morbidity and mortality, is substantial. In the United States, nontyphoidal Salmonella species are estimated to cause 1 million foodborne illnesses [8] and are the leading cause of death among foodborne bacterial pathogens [9]. Across the 27 member states of the European Union (EU), there were estimated to be 6.2 million cases of salmonellosis in 2009 [10]. In a population-based study in the United Kingdom (UK) in 2008–2009, there were >38 600 estimated cases and nearly 11 300 patients presenting to a primary care physician [11]. This represented a marked reduction in incidence compared with a similar study conducted more than a decade earlier [12, 13]. The purpose of this article is to discuss the factors associated with a substantial decline in nontyphoidal salmonellosis in the United Kingdom since the mid-1990s. A BRIEF HISTORY OF NONTYPHOIDAL SALMONELLOSIS IN THE UNITED KINGDOM Remarkable changes in the epidemiology of human nontyphoidal salmonellosis have occurred in the United Kingdom over the last century. Prior to 1942, the dominant foodborne salmonellas causing disease were Salmonella enterica subspecies enterica serovar Typhimurium, Salmonella Enteritidis, Salmonella Thompson, Salmonella Newport, Salmonella Bovismorbificans, and Salmonella Choleraesuis [14]. Salmonella Typhimurium remained the dominant serovar causing human disease for much of the 20th century, although there were fluctuations in other salmonellas in the “top 10” over time. For example, Salmonella Agona emerged as an important serovar in the 1960s following its introduction into pigs and poultry through contaminated fish meal imported from Peru [15]. Salmonella Hadar became the second most commonly isolated cause of human nontyphoidal salmonellosis in the mid-1970s when particular genetic lines of turkeys became infected [15]. Against this background, the incidence of Salmonella Enteritidis increased fairly gradually from around 150 to approximately 900 laboratory-confirmed cases per year between 1961 and 1980 [16]. During this time, phage type (PT) 8 dominated and was responsible for several turkey-associated outbreaks in the late 1960s [16]. By 1975 Salmonella Enteritidis was consistently the second or third most frequently isolated serovar annually [17]. Between 1981 and 1991, the incidence of nontyphoidal salmonellosis in the United Kingdom rose by >170% [18], driven primarily by an epidemic of Salmonella Enteritidis PT4 [16, 18–20] (Figure 1). In 1981 Salmonella Enteritidis accounted for approximately 10% of human Salmonella illnesses, but by 1993 this proportion had risen to nearly 70% [20]. In the early 1980s, PT4 overtook PT8 to become the predominant phage type in 1983, comprising 46% of isolations that year. By 1988 PT4 had risen to account for 81% of Salmonella Enteritidis strains isolated [16] and had ended the political career of a prominent government minister [21]. The United Kingdom was not alone; analysis of data submitted to the World Health Organization's Salmonella surveillance system showed that Salmonella Enteritidis in the late 1980s was increasing on several continents, with North America, South America, and Europe appearing to bear the brunt [22]. Figure 1. Laboratory reports of human Salmonella cases in the United Kingdom, 1981–2010. Abbreviations: CMO, Chief Medical Officer; PT, phage type. EVIDENCE THAT THE DECLINE IN SALMONELLA IS REAL Compelling evidence that the decline in Salmonella is real is derived from 3 sources. The first comprises 2 population-based prospective cohort studies of infectious intestinal disease (IID) in the community conducted more than a decade apart [11–13]. The primary outcome measures in both studies were estimates of the incidence of IID in the community, presenting to primary healthcare and reported to national surveillance. They were conducted using identical study designs and case definitions and employed similar microbiological methods, the exception being that molecular microbiological techniques were used alongside traditional microbiology in the second study of infectious intestinal disease (IID2). In the first study of infectious intestinal disease (IID1) in 1993–1996, the incidence of nontyphoidal Salmonella in the community in England was 2.2 cases per 1000 person-years (95% confidence interval [CI], 1.1–4.3) but by 2008–2009 this had fallen to 0.7 cases per 1000 person-years (95% CI, .2–3.0). For nontyphoidal Salmonella cases presenting to primary care in England, the incidence rate had fallen from 1.6 cases per 1000 person-years (95% CI, 1.2–2.1) in IID1 to 0.2 cases per 1000 person-years (95% CI, .1–.5) in IID2. The decline in incidence in the community was not statistically significant because in IID2 the study power was insufficient to detect statistically significant changes in organism-specific incidence—to do this would have required >100 000 person-years of follow-up, based on incidence rates in IID1. Nevertheless, the reduction in presentations to primary healthcare was statistically significant. Second, there has been a substantial fall in laboratory-confirmed Salmonella cases reported to national surveillance (Figure 1). Phage typing of Salmonella Enteritidis was implemented from 1981 as an addition to the centralized, national service already in existence for confirmation and further typing [17], and all clinical diagnostic laboratories have continued to refer all Salmonella isolates to the national reference laboratories since that date. At the beginning of 1992, 2 separate national Salmonella databases were merged to form a single national dataset, which became patient-based rather than isolate-based, thus eliminating potential duplication if people were tested more than once [18]. Laboratory testing methods have remained constant since then and reporting algorithms have not changed [23], suggesting that the reduction in Salmonella is real. When Salmonella Enteritidis PT4 peaked in 1993 in the United Kingdom, >18 000 laboratory-confirmed cases of illness were recorded in national surveillance statistics, yet by 2010 PT4 isolations had fallen to just 459 [24]. Thus, the decline in nontyphoidal salmonellosis witnessed in the United Kingdom in recent years reflects this major contraction in reports of Salmonella Enteritidis PT4. Finally, outbreaks of salmonellosis have declined. Standardized reporting of outbreaks of gastrointestinal infection was introduced in 1992 in England and Wales and in 1996 in Scotland partly in response to the increase in nontyphoidal salmonellosis. A foodborne outbreak is defined in European legislation as “an incidence, observed under given circumstances, of two of more human cases of the same disease and/or infection, or a situation in which the observed number of human cases exceeds the expected number and where the cases are linked, or are probably linked, to the same source” [25]. Between 1992 and 2008, foodborne Salmonella outbreaks reported to national surveillance fell from nearly 150 per year to just over 20 annually, and the pattern of decline closely mirrors that of laboratory-confirmed cases [25]. EPIDEMIOLOGY OF SALMONELLA ENTERITIDIS IN THE UNITED KINGDOM Epidemiologic investigations of outbreaks and sporadic cases repeatedly showed that Salmonella Enteritidis PT4 infection in humans was frequently associated with consumption of poultry meat and hens' eggs on both sides of the Atlantic [25–31]. In nearly 2500 foodborne disease outbreaks reported to the UK Health Protection Agency between 1992 and 2008, Salmonella species accounted for 47% of all outbreaks, 46% of cases, 70% of hospital admissions, and 76% of deaths [25]. Salmonella Enteritidis PT4 was the causative organism in 51% of all the Salmonella outbreaks throughout the surveillance period but the percentage of outbreaks caused by Salmonella Enteritidis PT4 declined from the late 1990s onward. At least one food vehicle was identified in 75% of outbreaks reported, and poultry meat was the vehicle most often implicated (19% of outbreaks). Desserts were also implicated commonly (11% of outbreaks), and raw shell eggs were used as an ingredient in 70% of these desserts. Eggs were implicated separately in an additional 6% of outbreaks. Analysis of outbreak data also showed that nearly 50% of foodborne Salmonella outbreaks occurred in the food service/catering sector. Salmonella Gallinarum and Salmonella Pullorum had been the dominant Salmonella serovars in UK poultry until the early 1970s. These strains both caused clinical disease in the birds and were virtually eradicated by a combination of slaughtering of seropositive hens and vaccination [20]. However, the ecological niche left by these 2 serovars was filled by Salmonella Enteritidis. Complete genome sequencing of a host-promiscuous Salmonella Enteritidis PT4 isolate (P125109) and a chicken-restricted Salmonella Gallinarum isolate (287/91) has indicated that Salmonella Gallinarum 287/91 is a recently evolved descendent of Salmonella Enteritidis [32]. Importantly, Salmonella Enteritidis infects poultry without causing overt disease, which probably facilitated its rapid spread internationally [20]. Another key feature of Salmonella Enteritidis is colonization of the reproductive tissues leading to the production of eggs with Salmonella-positive contents [20, 33] and, in some eggs, the numbers of organisms can be very high [34]. CONTROLLING SALMONELLOSIS AND OTHER FOODBORNE ILLNESSES In August 1988, as evidence of a link between Salmonella Enteritidis PT4 and raw shell eggs strengthened, the Chief Medical Officer issued advice to consumers to avoid eating raw eggs or uncooked foods in which raw eggs were an ingredient. In December of the same year, he issued further advice to vulnerable people such as the elderly, individuals with chronic illness, infants, and pregnant women. They were counseled only to eat eggs that had been cooked until the yolks and whites were solid [18]. Caterers were encouraged to use pasteurized eggs, especially where foodstuffs were not going to be cooked further (eg, mayonnaise), and it was recommended that eggs be considered short shelf-life products. They should be refrigerated 600 000 birds from 58 infected flocks were slaughtered. In 1992, <300 000 birds from 38 infected flocks were slaughtered [18]. Alongside legislation was a voluntary, industry-led vaccination scheme that began in broiler-breeder flocks in 1994 and in laying flocks in 1998 [16]. A “Lion Mark,” stamped on eggs, which had been introduced in 1957 but dropped by 1971, was revived in 1998 (http://www.lioneggs.co.uk/page/lionmark). The Lion Mark can only be used by subscribers to the British Egg Industry Council for eggs that have been produced in accordance with UK and EU law and the Lion Quality Code of Practice. The code of practice requires mandatory vaccination of all pullets destined to lay Lion eggs against Salmonella; independent auditing; full traceability of hens, eggs, and feed; and a “best-before” date stamped on the shell and pack, in addition to on-farm stamping of eggs and packing station hygiene controls. When, in 1989, a Junior Health Minister stated in a British television interview that “Most of the egg production in this country, sadly, is now infected with Salmonella,” the sale of eggs collapsed by 60% almost overnight. Moreover, despite government efforts to improve the safety of eggs, sales continued to fall by around 8% per year over the next 10 years, which was a disaster for the industry. The British Egg Industry Service began a major consumer research program in 1997 and, in 1998, the majority of UK producers and packers made a voluntary investment of £8 million to assist the British Egg Industry Council to relaunch British eggs. A total of £4 million was spent on the stringent new Code of Practice described above, and £4 million supported a new promotional campaign to restore consumer confidence and increase consumption. The cost of the vaccination program (including Lion sampling and testing) is estimated to be around £52 million to date (Mark Williams, written personal communication, September 2012). However, between 1998 and 2009, the egg market grew from 9.8 billion to 11 billion eggs per year, and Lion eggs now account for around 85% of the total market. Within the retail sector the market share of Lion eggs share rose from approximately 60% in 1998 to 95% in 2010 (http://www.lioneggs.co.uk/files/lioneggs.co.uk/pdfs/marketing.pdf). Alas, Salmonella was not the only “food scare” during the 1980s and 1990s. Scandals surrounding, for example, bovine spongiform encephalopathy in the United Kingdom, dioxins in Belgium, and Salmonella EU-wide prompted new legislation providing for a risk-based “farm to fork” approach to food safety policy, which was enacted in 2002 (European General Food Law [Regulation (EC) No. 178/2002]) [24]. EU Zoonoses Regulation (EC) No. 2160/2003 required member states to take effective measures to detect and control Salmonella species of public health significance in specified animal species at all relevant stages of production [24]. Each EU member state was obliged to undertake a standardized baseline survey to determine the prevalence of Salmonella within their industry sectors. EC Regulation (EC) 1168/2006 laid down an annual reduction target for Salmonella Enteritidis and Salmonella Typhimurium for each member state. NATIONAL CONTROL PROGRAMS FOR SALMONELLA IN THE POULTRY SECTOR Four National Control Programmes (NCPs) for Salmonella have been implemented in the UK poultry sector between 2007 and 2010. These postdate the rapid decline in Salmonella Enteritidis in the United Kingdom but are designed to achieve and maintain low rates EU-wide. For the most part, the targets set by the EU have already been met or exceeded in the United Kingdom [24]. The NCP for breeding chickens (implemented in 2007): The target for this NCP was that no more than 1% of adult breeding flocks should be infected with 5 specific regulated serovars (Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Hadar, Salmonella Infantis, and Salmonella Virchow) by the end of 2009. Results from UK holdings have been significantly below the EU target of 1% every year for the last 4 years [24]. The NCP for commercial laying chickens (implemented in 2008): An EU-wide baseline survey of commercial laying chicken flock holdings was undertaken in 2004–2005. In a survey of Salmonella species on 454 commercial layer flock holdings in the United Kingdom, 54 (11.7%) were Salmonella positive [35]. Salmonella Enteritidis was the serovar most commonly identified (prevalence = 5.8%) and PTs 4, 6, 7, and 35 comprised 70% of isolates. Salmonella Typhimurium was the second most commonly identified serovar (prevalence = 1.8%). The UK prevalence figures were among the lowest of the major egg-producing countries (7.9% of holdings positive compared with a 20.4% average across the EU) [36]. Across the EU, the incidence rate of salmonellosis in member states varies between 16 and 11 800 per 100 000 population and has been shown to be significantly correlated with the prevalence of Salmonella Enteritidis in laying hens [10], so controlling levels of Salmonella Enteritidis in laying flocks is important for improving public health. The NCP for broilers (implemented in 2009): The target for this NCP was that no more than 1% of flocks should be infected with Salmonella Enteritidis and Salmonella Typhimurium by the end of 2011. In a baseline survey of broiler chickens in 2005–2006 in the United Kingdom, the prevalence of Salmonella Enteritidis and Salmonella Typhimurium was very low (0.2% [37] compared with an EU average of 11.0% [38]) and remains well below the EU target [24]. The NCP for turkeys (implemented in 2010): A baseline survey for Salmonella in turkey breeding and fattening flocks was carried out across the EU in 2006–2007. In the United Kingdom, the prevalence of Salmonella in breeding flock holdings was 20.1% and in fattening flocks the holdings prevalence was 37.7% [39]. The flock prevalence of Salmonella Typhimurium was very low on breeding holdings at 0.7% (EU weighted average = 1.8%) but higher on fattening holdings at 4.6% (EU weighted average = 3.7%) [24]. The target for Salmonella reduction is that only 1% of breeding flocks and 1% of fattening flocks should be positive by the end of 2012. Early indications are that this target will be met. WHAT NEXT? There is no room for complacency. During the 2000s, new Salmonella problems emerged. Notable among these were national outbreaks of Salmonella Enteritidis PT14b linked to raw shell eggs originating in Spain [40, 41]. Unbelievably, perhaps, hospital caterers in the United Kingdom were found serving raw shell eggs again to patients, with consequent outbreaks [42]. The first outbreak of Salmonella Typhimurium PT8 linked to consumption of duck eggs since 1949 occurred in the United Kingdom [43], and Salmonella outbreaks linked to fresh produce were increasingly recognized [44, 45], reflecting a pattern also seen in the United States [46]. CONCLUSIONS The nature of public health interventions often means that evaluating their impact is complex as they are often implemented in combination and/or simultaneously. It is interesting to reflect on the fact that the various legislative measures in the United Kingdom in the late 1980s and early 1990s appear to have slowed down the increase in Salmonella Enteritidis PT4, whereas the decrease in laboratory-confirmed human cases coincides quite closely with the introduction of vaccination programs in broiler-breeder and laying flocks and prior to much of the EU legislation being implemented. It is probable that no single measure contributed to the decline in Salmonella Enteritidis PT4 and that the combination of measures was successful, but the temporal relationship between vaccination programs and the reduction in human disease is compelling and suggests that these programs have made a major contribution to improving public health. There has also been a reduction in reported human salmonellosis cases across the EU (on average 12% per year between 2005 and 2009). The European Commission and European Food Safety Authority are attributing this, at least in part, to successful control of Salmonella in broiler, laying, and breeding hen flocks and eggs [24]. If success in public health is defined by illnesses averted, then the story of Salmonella Enteritidis PT4 in the United Kingdom, which has come down and stayed down, is good news. However, history teaches us that something else may come along to take its place. Robust surveillance, incorporating state-of-the-art microbiological, epidemiological, and biostatistical methods, and maintaining a prompt and comprehensive response to outbreaks is just as important now as it ever was.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect of Salmonella vaccination of breeder chickens on contamination of broiler chicken carcasses in integrated poultry operations.

            While measures to control carcass contamination with Salmonella at the processing plant have been implemented with some success, on-farm interventions that reduce Salmonella prevalence in meat birds entering the processing plant have not translated well on a commercial scale. We determined the impact of Salmonella vaccination on commercial poultry operations by monitoring four vaccinated and four nonvaccinated breeder (parental) chicken flocks and comparing Salmonella prevalences in these flocks and their broiler, meat bird progeny. For one poultry company, their young breeders were vaccinated by using a live-attenuated Salmonella enterica serovar Typhimurium vaccine (Megan VAC-1) followed by a killed Salmonella bacterin consisting of S. enterica serovar Berta and S. enterica serovar Kentucky. The other participating poultry company did not vaccinate their breeders or broilers. The analysis revealed that vaccinated hens had a lower prevalence of Salmonella in the ceca (38.3% versus 64.2%; P < 0.001) and the reproductive tracts (14.22% versus 51.7%; P < 0.001). We also observed a lower Salmonella prevalence in broiler chicks (18.1% versus 33.5%; P < 0.001), acquired from vaccinated breeders, when placed at the broiler farms contracted with the poultry company. Broiler chicken farms populated with chicks from vaccinated breeders also tended to have fewer environmental samples containing Salmonella (14.4% versus 30.1%; P < 0.001). There was a lower Salmonella prevalence in broilers entering the processing plants (23.4% versus 33.5%; P < 0.001) for the poultry company that utilized this Salmonella vaccination program for its breeders. Investigation of other company-associated factors did not indicate that the difference between companies could be attributed to measures other than the vaccination program.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Evaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern Academic Hospital.

              The BioFire FilmArray® Gastrointestinal Panel (GIP) was implemented to replace traditional stool culture and enzyme immunoassay (EIA) testing for stool pathogens. The purpose of this study was to evaluate the detection rate, incidence of coinfection, and culture recovery rate of gastrointestinal (GI) pathogens detected by the GIP over a 1-year period. A total of 2257 stools collected from January to December 2015 were tested using the GIP. Clostridium difficile colonization was also evaluated by an antigen/toxin EIA and confirmatory polymerase chain reaction (PCR). The GIP detected one pathogen in 911 (40.4%) specimens. Coinfections were detected in 176 (7.8%) of these specimens. The most frequently detected pathogens were C. difficile (15.2%), norovirus (8.9%), enteropathogenic Escherichia coli (7.1%), enteroaggregative E. coli (3.4%), Campylobacter spp. (2.3%), and sapovirus (2.0%). Each of the remaining GIP targets had a detection rate of ≤1.6%. The recovery of bacteria for public health investigations varied, with rates as high as 77% for Salmonella to as low as 30% for Yersinia enterocolitica. Of stools positive for C. difficile on the GIP that were tested by EIA, only 42.7% (88/206) were found to be producing detectable toxin. Overall, the implementation of the GIP resulted in high detection rates of GI pathogens, including the frequent detection of coinfections. This is a promising test to streamline the testing of agents causing infectious gastroenteritis from multiple tests down to a single order with limited hands-on time. Ongoing studies will need to assess the impact that the GIP has on downstream patient care and public health practices.
                Bookmark

                Author and article information

                Journal
                MMWR Morb Mortal Wkly Rep
                MMWR Morb. Mortal. Wkly. Rep
                WR
                Morbidity and Mortality Weekly Report
                Centers for Disease Control and Prevention
                0149-2195
                1545-861X
                23 March 2018
                23 March 2018
                : 67
                : 11
                : 324-328
                Affiliations
                Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC; Oregon Health Authority; Tennessee Department of Health; Connecticut Department of Public Health; Colorado Department of Public Health and Environment; University of New Mexico, Albuquerque; New York State Department of Health; Maryland Department of Health; Minnesota Department of Health; Georgia Department of Public Health; California Department of Public Health; Food Safety and Inspection Service, U.S. Department of Agriculture, Atlanta, Georgia; Center for Food Safety and Applied Nutrition, Food and Drug Administration, Silver Spring, Maryland.
                Author notes
                Corresponding author: Ellyn Marder, emarder1@ 123456cdc.gov , 404-718-4722.
                Article
                mm6711a3
                10.15585/mmwr.mm6711a3
                5868202
                29565841
                bc237c77-e740-4eb8-81b1-c6f60ff841bd

                All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.

                History
                Categories
                Full Report

                Comments

                Comment on this article